42

42 Prescriptions directing supply for dispensing over time

(1) This section applies if a pre‑commencement prescription directed the supply of a specified quantity or number of units (whether expressed as a total or as a dose) to be dispensed over a specified period of time (the directed dispensing period). Deemed variation of application of determination of maximum number or quantity of units (2) If the specified quantity or number of units, or the quantity or number of units required for the doses over the directed dispensing period, is more than the maximum quantity or number of units mentioned in Schedule 1 for the pharmaceutical benefit to be supplied on the basis of the prescription: (a) the application of the determination of the maximum quantity or number of units under paragraph 85A(2)(a) of the Act for the benefit is taken to have been varied under section 30 of the Regulations; and (b) the prescription is taken to have been authorised in accordance with subsection 30(4) of the Regulations; and (c) the number P2023OD is taken to have been allotted to, and marked on, the prescription as mentioned in subsection 30(5) of the Regulations. Deemed modification of prescription—remaining period of up to 28 days (3) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the period remaining in the directed dispensing period (the remaining period) is not more than 28 days, the prescription is taken to direct the supply on one occasion of the total quantity or number of units required for the remaining period. Deemed modification of prescription—remaining period of 29 to 55 days (4) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining period is more than 28 days but not more than 55 days, the prescription is taken to direct the supply on one occasion of the total quantity or number of units required for 28 days. Deemed modification of prescription—remaining period of 56 to 83 days (5) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining period is more than 55 days but not more than 83 days, the prescription is taken to direct: (a) the supply on any one occasion of the total quantity or number of units required for 28 days; and (b) that the supply be repeated once. Deemed modification of prescription—remaining period of 84 days or more (6) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining period is 84 days or more, the prescription is taken to direct: (a) the supply on any one occasion of the total quantity or number of units required for 28 days; and (b) that the supply be repeated twice.